中间体1 - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

274693-55-9

1-金刚烷甲基酮中间体;
1-金刚烷甲基酮中间体;
替卡格雷中间体1;
2-[[(3AR,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-

1-Acetyladamantane Intermediate;
1-Acetyladamantane Intermediate;
2-(6-Amino-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4-yloxy)-ethanol;
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol;
2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol;
Ticagrelor InterMediate1

无

特拉匹伟/VX950中间体1;
特拉匹伟/VX950中间体1;
(1S,3AR,6AS)-ETHYL OCTAHYDROCYCLOPENTA[C]PYRROLE-1-CARBO

(1S,3AR,6AS)-OCTAHYDRO-CYCLOPENTA[C]PYRROLE-1-CARBOXYLIC ACID ETHYL ESTER;
(1S,3AR,6AS)-OCTAHYDRO-CYCLOPENTA[C]PYRROLE-1-CARBOXYLIC ACID ETHYL ESTER;
Telaprevir/VX950 Intermediate 1

雷美替胺中间体12;
雷美替胺中间体12;
2-(1,6,7,8-四氢-2H-茚并[5,4-B]呋喃-8-基)乙胺盐酸盐;
1,6,7,8-四氢-2H-茚并[5,4-B]呋喃-8-乙胺盐酸盐

2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylaMine hydrochloride;
2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylaMine hydrochloride;
1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-ethanamine hydrochloride;
2H-Indeno[5,4-b]furan-8-ethanaMine, 1,6,7,8-tetrahydro- (hydrochloride)(1:1)

(3AR,4S,6R,6AS)-6-[[5-氨基-6-氯-2-(丙硫基)-4-嘧啶基]氨基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二恶茂-4-醇;
(3AR,4S,6R,6AS)-6-[[5-氨基-6-氯-2-(丙硫基)-4-嘧啶基]氨基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二恶茂-4-醇;
替卡格雷中间体10;
(3AR,4S,6R,6AS)-6-(5-胺基-6-氯-2-丙硫基-4-吡啶基)氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-醇

(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol;
(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol;
(3aR,4S,6R,6aS)-6-((5-aMino-6-chloro-2-(propylthio)pyriMidin-4-yl)aMino)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol;
4H-Cyclopenta-1,3-dioxol-4-ol, 6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-d iMethyl-, (3aR,4S,6R,6aS)-

无

2-[[(3AR,4S,6R,6AS)-6-[7-氯-5-(丙硫基)-3H-1,2,3-三氮唑并[4,5-D]嘧啶-3-基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二恶茂-4-基]氧基]乙醇;
2-[[(3AR,4S,6R,6AS)-6-[7-氯-5-(丙硫基)-3H-1,2,3-三氮唑并[4,5-D]嘧啶-3-基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二恶茂-4-基]氧基]乙醇;
替卡格雷N-2;
替卡格雷中间体13;
2-[[(3AR,4S,6R,6AS)-6-[7-氯-5-丙硫基-3H-1,2,3-三唑[4,5-D]嘧啶-3-基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧]-乙醇

2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol;
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol;
Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyriMidin-3-yl]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-

无

suvorexant中间体1

(R)-benzyl 5-methyl-1,4-diazepane-1-carboxylate；;
1H-1,4-Diazepine-1-carboxylic acid, hexahydro-5-Methyl-, phenylMethyl ester, (5R)-

无